Search research articles
Contact Us
Filters
Showing results (211-220 of 398) with videos related to
Page
of 40
Sort By:
Human Genetics
|
July 4, 2014
Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma
Michael J Kelley, Jianxin Shi, Bari Ballew, et al.
Journal of the National Cancer Institute
|
April 22, 2015
Germline TP53 variants and susceptibility to osteosarcoma
Lisa Mirabello, Meredith Yeager, Phuong L Mai, et al.
Viruses
|
October 26, 2021
Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes
Maisa Pinheiro, Ariana Harari, Mark Schiffman, et al.
Oncotarget
|
December 1, 2016
Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes
Danielle M Karyadi, Milan S Geybels, Eric Karlins, et al.
The Prostate
|
January 16, 2008
TNF polymorphisms and prostate cancer risk
Kim N Danforth, Carmen Rodriguez, Richard B Hayes, et al.
Lancet (London, England)
|
August 23, 2005
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
Montserrat García-Closas, Núria Malats, Debra Silverman, et al.
Nature Communications
|
June 2, 2026
HPV16 genetic variation provides evidence of positive natural selection driven by HLA class I
Chase W Nelson, Sambit K Mishra, Michael Dean, et al.
Human Mutation
|
July 24, 2010
A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiency
Hong-Ying Wang, Vivek Gopalan, Ivona Aksentijevich, et al.
Nature Genetics
|
January 24, 2009
Variation in KLK genes, prostate-specific antigen and risk of prostate cancer
Jiyoung Ahn, Sonja I Berndt, Sholom Wacholder, et al.
Cancer Causes & Control : CCC
|
August 2, 2013
Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk
Mahboobeh Safaeian, Preetha Rajaraman, Patricia Hartge, et al.
Page
of 40
Search research articles
Search
Showing results (211-220 of 398) with videos related to
Sort By:
Page
of 40
Human Genetics
|
July 4, 2014
Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma
Michael J Kelley, Jianxin Shi, Bari Ballew, et al.
Journal of the National Cancer Institute
|
April 22, 2015
Germline TP53 variants and susceptibility to osteosarcoma
Lisa Mirabello, Meredith Yeager, Phuong L Mai, et al.
Viruses
|
October 26, 2021
Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes
Maisa Pinheiro, Ariana Harari, Mark Schiffman, et al.
Oncotarget
|
December 1, 2016
Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes
Danielle M Karyadi, Milan S Geybels, Eric Karlins, et al.
The Prostate
|
January 16, 2008
TNF polymorphisms and prostate cancer risk
Kim N Danforth, Carmen Rodriguez, Richard B Hayes, et al.
Lancet (London, England)
|
August 23, 2005
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
Montserrat García-Closas, Núria Malats, Debra Silverman, et al.
Nature Communications
|
June 2, 2026
HPV16 genetic variation provides evidence of positive natural selection driven by HLA class I
Chase W Nelson, Sambit K Mishra, Michael Dean, et al.
Human Mutation
|
July 24, 2010
A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiency
Hong-Ying Wang, Vivek Gopalan, Ivona Aksentijevich, et al.
Nature Genetics
|
January 24, 2009
Variation in KLK genes, prostate-specific antigen and risk of prostate cancer
Jiyoung Ahn, Sonja I Berndt, Sholom Wacholder, et al.
Cancer Causes & Control : CCC
|
August 2, 2013
Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk
Mahboobeh Safaeian, Preetha Rajaraman, Patricia Hartge, et al.
Page
of 40